Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb

Prellis Biologics, Inc. announced that it has entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb utilizing Prellis Biologics’ first-in-class externalized human immune system based on human lymph node organoids.